Related Experiment Videos
Acute-phase proteins in patients with systemic sclerosis
E J Kucharz1, E Grucka-Mamczar, A Mamczar
1Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland.
Clinical Rheumatology
|May 3, 2000
Summary
Systemic sclerosis patients show an impaired acute phase response. Levels of specific acute-phase proteins like haptoglobin were altered, indicating a weakened inflammatory reaction in early disease stages.
Area of Science:
- Rheumatology
- Clinical Immunology
- Biochemistry
Background:
- Systemic sclerosis is an autoimmune disease characterized by fibrosis.
- The acute phase response is a key immune mechanism.
- Understanding the acute phase response in systemic sclerosis is crucial for disease management.
Purpose of the Study:
- To investigate the acute phase protein profile in patients with early systemic sclerosis.
- To determine if systemic sclerosis is associated with an altered acute phase response.
Main Methods:
- Serum samples were collected from 20 women with systemic sclerosis (disease duration < 5 years) and 10 healthy controls.
- Levels of specific acute-phase proteins were quantified.
- Statistical analysis was performed to compare patient and control groups.
Main Results:
- Patients with systemic sclerosis exhibited elevated levels of haptoglobin, alpha1-acid glycoprotein, complement component C3, and alpha2-macroglobulin compared to controls.
- These findings suggest a dysregulated acute phase response in early systemic sclerosis.
Conclusions:
- The acute phase response appears to be impaired in patients with systemic sclerosis.
- Altered acute-phase protein levels may serve as potential biomarkers for disease activity or progression.